-
Green Energy Chemical Company Starts-Up, Raises $15M
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis.
-
Data Support Placebo Group Alternatives in Rare Disease Trials
Findings from a review of medical data and records indicate matched genetic control groups may not be needed in clinical trials testing treatments for Duchenne muscular dystrophy.
-
AI-Aided Mobile App Shown to Screen for Melanoma
The developer of an app using algorithms to analyze images of skin lesions says clinical trial findings show the system detects melanoma more reliably than some physicians.
-
Allergy Antibody Biotech Gains $40M in New Funds
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round.
-
Infographic – Corp. Venture Investments Dip in 2022
Venture capital investments by corporations in start-ups declined globally in 2022, but remained at historically high levels, while the number of deals stayed about the same as 2021.
-
Start-Up Creating Software to Simplify Biomedical Analytics
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data.
-
Autism Device Company Gains Venture Funds, Joins Incubator
A new company creating precision light-activated treatments for autism spectrum disorder symptoms is raising more seed funds and joining a start-up incubator program.
-
Collaboration Developing Microbiome Boost to Cancer Immunotherapy
A biotechnology company creating treatments that work with gut microbes is partnering with M.D. Anderson Cancer Center on more effective cancer immunotherapies.
-
Light-Activated Treatment Kills Covid-19 Nasal Viruses
Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue.
-
Implanted Tissue Shown to Produce Thyroid Hormones
In a preclinical test, thyroid tissue earlier removed from lab animals was re-implanted in a protective pouch, which generates production of key hormones by the animals.